correspondence: Identification of TINF2 gene mutations in adult Japanese patients with acquired bone marrow failure syndromes
H. Yamaguchi,K. Inokuchi,Junko Takeuchi,H. Tamai,Y. Mitamura,F. Kosaka,H. Ly,K. Dan
DOI: https://doi.org/10.1111/j.1365-2141.2010.08278.x
2010-09-01
British Journal of Haematology
Abstract:Haematologica, 118, 27–29. Finnegan, D.P., Kettle, P., Drake, M., Matthews, C., Alexander, H.D., Popat, R., Cavanagh, J.D., Wachsman, W. & Morris, T. (2006) Bortezomib is effective in primary plasma cell leukemia. Leukaemia & Lymphoma, 47, 1670–1673. Garcia-Sanz, R., Orfao, A., Gonzalez, M., Tabernero, M.D., Blade, J., Moro, M.J., Fernandez-Calvo, J., Sanz, M.A., PerezSimon, J.A., Rasillo, A. & Miguel, J.F. (1999) Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood, 93, 1032–1037. Gemmel, C., Cremer, F.W., Weis, M., Witzens, M., Moldenhauer, G., Koniczek, K.H., Imbach, U., Ho, A.D., Moos, M. & Goldschmidt, H. (2002) Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation. Annals of Hematology, 81, 119–123. Oka, S., Yokote, T., Akioka, T., Hara, S., Yamano, T., Tsuji, M. & Hanafusa, T. (2006) Successful treatment of multi-agent chemotherapy with rituximab for IgM plasma cell leukemia. Leukemia Research, 30, 1581–1583. RuizArguelles, G.J. & San Miguel, J.F. (1994) Cell surface markers in multiple myeloma. Mayo Clinic Proceedings, 69, 684–690. Saccaro, S., Fonseca, R., Veillon, D.M., Cotelingam, J., Nordberg, M.L., Bredeson, C., Glass, J. & Munker, R. (2005) Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. American Journal of Hematology, 78, 288–294. Tanioka, F., Tamashima, S., Shimizu, S., Kobayashi, H., Kobayashi, Y. & Sugimura, H. (2003) A case of primary plasma cell leukemia with hairycell morphology and k -type Bence-Jones protein. Immunohistochemical and molecular analysis. Japanese Journal of Clinical Oncology, 33, 232–237. Walters, M., Olteanu, H., Van Tuinen, P. & Kroft, S.H. (2010) CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group. British Journal of Haematology, 149, 292–293.